Inogen (INGN) Preferred Stock Liabilities (2013)
Inogen's (INGN) quarterly Preferred Stock Liabilities came in at $260000.0 in Q4 2013.
Inogen (INGN) Preferred Stock Liabilities (2013) Analysis & Trends
Inogen (INGN) has 1 years of Preferred Stock Liabilities data on file, last reported at $260000.0 in Q4 2013.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $260000.0 in Q4 2013; TTM through Dec 2013 was $260000.0, a N/A change from a year earlier, with the FY2013 full-year figure at $260000.0, changed N/A from the prior year.
- Preferred Stock Liabilities for Q4 2013 stood at $260000.0.
- Over the last five years, Preferred Stock Liabilities for INGN reached as high as $260000.0 in Q4 2013 and fell as low as $260000.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 260,000.00 |